Old Web
English
Sign In
Acemap
>
authorDetail
>
Jonathan L. Bramson
Jonathan L. Bramson
McMaster-Carr
Medicine
Immune system
Antigen
Immunology
Pathology
4
Papers
27
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with combination ipilimumab/nivolumab for metastatic kidney cancer (CYTOSHRINK).
2020
Journal of Clinical Oncology
Aly-Khan A. Lalani
Anand Swaminath
Gregory R. Pond
Anil Kapoor
William Chu
Jonathan L. Bramson
Michael G. Surette
Mark Levine
Sebastien J. Hotte
Show All
Source
Cite
Save
Citations (6)
Phase I study of oncolytic virus (OV) MG1 maraba/MAGE-A3 (MG1MA3), with and without transgenic MAGE-A3 adenovirus vaccine (AdMA3) in incurable advanced/metastatic MAGE-A3-expressing solid tumours: CCTG IND.214.
2017
Journal of Clinical Oncology
Derek J. Jonker
Sebastien J. Hotte
Albiruni R. A. Razak
Daniel John Renouf
Brian D. Lichty
John C. Bell
Jean Powers
Caroline Breitbach
David F. Stojdl
Kyle B. Stephenson
Jonathan L. Bramson
Jeff Hummel
Chantal G Lemay
Jean-Claude Cutz
Julie Wells
Robin Eady
Xiaoqun Sun
Dongsheng Tu
Janet Dancey
Show All
Source
Cite
Save
Citations (5)
Induction of an Immune-Protective T-Cell Repertoire With Diverse Genetic Coverage by a Novel Viral-Vectored Tuberculosis Vaccine in Humans
2016
The Journal of Infectious Diseases
Mangalakumari Jeyanathan
Daniela Damjanovic
Yushi Yao
Jonathan L. Bramson
Fiona Smaill
Zhou Xing
Show All
Source
Cite
Save
Citations (16)
the Target Antigen Damaging the Brain despite Sharing Intracranial Tumor Cells without Immunotherapy Can Reject
2010
Brian D. Lichty
Jonathan L. Bramson
Byram W. Bridle
Jian Li
Shucui Jiang
Ruby Chang
Show All
Source
Cite
Save
Citations (0)
1